The DOI matches its Crossref record.
Cardiovascular Responses to Sevoflurane: A Review
Abstract
Sevoflurane is a halogenated volatile anesthetic with a low blood:gas solubility and minimal pungency. If sevoflurane is shown to be safe and efficacious, it holds great promise for rapid induction of anesthesia when administered by mask, as well as for rapid elimination and awakening from anesthesia. Although sevoflurane has been in clinical use in Japan for several years and has been administered without evidence of adverse cardiovascular effects, additional clinical evaluation of the cardiovascular effects of sevoflurane in animals, human volunteers, and patients has been required prior to its approval for use in the United States. This review summarizes the effects of sevoflurane on the cardiovascular system. It is based on both published research and unpublished Food and Drug Administration Phase I and III single and multicenter trials of sevoflurane sponsored by Abbott Laboratories. This review will, wherever statistically possible, compare and contrast these data with other approved volatile anesthetics. The review is structured in sections that focus on different components of the circulatory system most relevant to the clinical anesthesiologist. Data derived from experimental animal preparations are presented separately from studies in both human volunteers and patient populations. Heart Rate and Rhythm Considerable interest has been generated concerning the effects of the newer volatile anesthetics on heart rate. This interest is in part because of the data indicating that desflurane (and to a lesser extent isoflurane) can initiate large increases in heart rate [1-3] that might predispose select patient populations to myocardial ischemia. In 1981, the initial human study in nonpremedicated volunteers evaluated 2%-3% sevoflurane over a 1-h period [4]. Heart rate was unchanged from conscious baseline throughout the study period. Further evidence of stable heart rates during the administration of sevoflurane was provided several years later by Manohar and Parks [5] in chronically instrumented healthy swine. Sevoflurane was given at 1 and 1.5 minimum alveolar anesthetic concentration (MAC) both with and without 50% nitrous oxide, and heart rate remained stable and unchanged from awake baseline throughout each anesthetic period. Despite the apparent stable heart rates in human volunteers and swine receiving sevoflurane, several studies in chronically instrumented dogs indicated that sevoflurane was associated with increases in heart rate [6,7]. Bernard et al. [6] and Harkin et al. [7] noted 30%-40% increases in heart rate from the awake state during the administration of 1.2-2.0 MAC sevoflurane. These increases were significantly larger than heart rate increases produced by equianesthetic concentrations of isoflurane. Additional data from nonpremedicated children also suggest that sevoflurane may be associated with small increases in heart rate [8]. Lerman et al. [8] administered sevoflurane via a mask and reported heart rate data from a measurement period immediately prior to tracheal intubation. In neonates and infants up to 3 yr of age, there were no changes in heart rate when sevoflurane was administered at approximate 1.0 MAC. However, in children 3-5 and 6-12 yr of age, heart rate increased approximate 3-10 bpm from awake baseline. Bradycardia did not occur in any of the 90 neonates, infants, and children under study. In two patients nodal rhythms were noted. In recent studies in volunteers and in patients, the administration of sevoflurane has been associated with stable and even lower heart rates compared with isoflurane. For example, in healthy, nonpremedicated young humans, aged 19-30 yr, sevoflurane (without adjuvants) was administered in doses ranging from 0.4 to 1.2 MAC (1%-3%) [9]. Heart rate was extremely stable throughout the administration period, and this was consistent with the 1981 work of Holaday and Smith [4]. When retrospectively compared with an identical study in an identical population receiving isoflurane, heart rates were lower during the administration of sevoflurane Figure 1. A direct comparison of heart rate responses to sevoflurane and isoflurane in elective surgery has been performed in healthy ASA grade I-II adult patients premedicated with intravenous midazolam and anesthetized with sodium thiopental [10]. The anesthetic gas concentrations were freely adjusted to maintain systolic pressure within +/- 20% of baseline, and the investigators noted that heart rates during the surgical period were significantly lower in patients receiving sevoflurane than in those receiving isoflurane Figure 2.Figure 1: Heart rate responses to increasing concentrations of sevoflurane, isoflurane, and desflurane in healthy volunteers. At lower MACs, neither desflurane nor sevoflurane was associated with increases in heart rate, whereas isoflurane caused an initial increase in heart rate that was sustained with increasing MAC. Desflurane at 1.5 MAC was associated with a significant increase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The aged cardiovascular risk patient
Priebe, H.-J. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.5.763 · Cited by 268
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Highland, J. N., Zanos, P., Riggs, L. M., Georgiou, P., Clark, S. M., Morris, P. J., Moaddel, R., Thomas, C. J., Zarate, C. A., Pereira, E. F. R., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000149 · Cited by 92
Metadata
- Authors
- Ebert, T. J., Harkin, C. P., & Muzi, M.
- Venue
- Anesthesia & Analgesia
- Published
- 1995-12
- Volume
- 81
- Issue
- Supplement
- Pages
- 11S-22S
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2043605986
- Cited by
- 226
- References
- 0
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Responses to Sevoflurane: A Review. https://app.cochat.ai/papers/10.1097/00000539-199512001-00003
- The paper
- Ebert, T. J., Harkin, C. P., & Muzi, M. (1995). Cardiovascular Responses to Sevoflurane: A Review. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199512001-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.